Levothyroxine Sodium
Product Images NDC 68788-9162

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68788-9162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levothyroxine Sodium Tablets Usp 1)

FDA Label Image

Levothyroxine Sodium Tablets, Usp 75mcg (0.075mg) (Levothyroxine Sodium Tablets Usp 4)

Levothyroxine Sodium Tablets, Usp 75mcg (0.075mg) (Levothyroxine Sodium Tablets Usp 4)
This is a cautionary text about the Federal law that prohibits the transfer of Levothyroxine P&F-E tablets to anyone other than the patient for whom it was prescribed. It is a generic drug for Synthroid and is manufactured by Lannett Co. Inc. in Philadelphia, PA. The tablets contain Levothyroxine Sodium USP 75mcg (0.075mg) and have an expiration date with a production number and lot or batch number. The Billing Chart Log is also mentioned.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.